FR

Cecile Bougeret


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Cecile Bougeret: Innovator in Cancer Treatment

Introduction

Cecile Bougeret is a notable inventor based in France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic agents for serious health conditions. Her work focuses on innovative compounds that target cancer and other viral infections.

Latest Patents

Cecile Bougeret holds two notable patents. The first is titled "Derivatives Of Indole For The Treatment Of Cancer, Viral Infections And Lung Diseases." This invention relates to a new class of indole derivatives that possess a specific MKlp2 inhibition profile, making them useful as therapeutic agents for treating cancer, viral infections, and lung diseases. The second patent is "Derives Piperazinyles Pour Le Traitement De Cancers." This invention involves piperazinyl derivatives and their use as drugs for cancer treatment, along with the pharmaceutical compositions containing these derivatives and the methods for synthesizing them.

Career Highlights

Throughout her career, Cecile has worked with prominent organizations such as Biokinesis and the Centre National De La Recherche Scientifique. Her experience in these institutions has allowed her to advance her research and contribute to significant medical advancements.

Collaborations

Cecile has collaborated with notable colleagues, including Catherine Guillou and Julien Rouleau. These partnerships have fostered a collaborative environment that enhances innovation and research in her field.

Conclusion

Cecile Bougeret is a pioneering inventor whose work in developing new therapeutic agents has the potential to impact the treatment of cancer and other diseases significantly. Her contributions to medicinal chemistry are noteworthy and reflect her dedication to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…